BRPI0818340A2 - N-Aryl Urea-based solid drug dispersion product - Google Patents

N-Aryl Urea-based solid drug dispersion product

Info

Publication number: BRPI0818340A2
Authority: BR; Brazil
Prior art keywords: based solid; solid drug; dispersion product; drug dispersion; aryl urea
Prior art date: 2007-10-19

Application number

Other languages

Portuguese (pt)

Inventor

Rudolf Schroeder

Tanja Heitermann

Original Assignee

Abbott Gmbh & Co Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-19

Filing date

2008-10-17

Publication date

2015-04-22

2008-10-17 Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg

2015-04-22 Publication of BRPI0818340A2 publication Critical patent/BRPI0818340A2/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0818340 2007-10-19 2008-10-17 N-Aryl Urea-based solid drug dispersion product BRPI0818340A2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US99961807P	2007-10-19	2007-10-19
PCT/EP2008/064076 WO2009050291A2 (en)	2007-10-19	2008-10-17	Solid dispersion product of n-aryl urea-based drugs

Publications (1)

Publication Number	Publication Date
BRPI0818340A2 true BRPI0818340A2 (en)	2015-04-22

Family

ID=40089463

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0818340 BRPI0818340A2 (en)	2007-10-19	2008-10-17	N-Aryl Urea-based solid drug dispersion product

Country Status (18)

Country	Link
EP (1)	EP2197425A2 (en)
JP (1)	JP2011500649A (en)
KR (1)	KR20100087170A (en)
CN (1)	CN101827584A (en)
AU (1)	AU2008313622A1 (en)
BR (1)	BRPI0818340A2 (en)
CA (1)	CA2699301A1 (en)
CO (1)	CO6270206A2 (en)
CR (1)	CR11442A (en)
DO (1)	DOP2010000117A (en)
EC (1)	ECSP10010183A (en)
GT (1)	GT201000102A (en)
MX (1)	MX2010004291A (en)
PA (1)	PA8800101A1 (en)
RU (1)	RU2010119929A (en)
UA (1)	UA100865C2 (en)
WO (1)	WO2009050291A2 (en)
ZA (1)	ZA201002095B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009100176A2 (en) *	2008-02-07	2009-08-13	Abbott Laboratories	Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
AR077975A1 (en)	2009-08-28	2011-10-05	Irm Llc	PIRAZOL PYRIMIDINE DERIVATIVES AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
KR20130109092A (en) *	2010-06-09	2013-10-07	아보트 러보러터리즈	Solid dispersions containing kinase inhibitors
MX354725B (en)	2011-11-11	2018-03-16	Novartis Ag	Method of treating a proliferative disease.
SG11201401260QA (en)	2011-11-23	2014-07-30	Novartis Ag	Pharmaceutical formulations
WO2014003677A1 (en) *	2012-06-28	2014-01-03	Xspray Microparticles Ab	Pharmaceutical compositions comprising solid dispersion particles containing tadalafil
WO2014003678A1 (en) *	2012-06-28	2014-01-03	Xspray Microparticles Ab	Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil
US12133911B2 (en)	2015-06-09	2024-11-05	Capsugel Belgium Nv	Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1959926A1 (en) *	2005-10-25	2008-08-27	Abbott Laboratories	Formulation comprising a drug of low water solubility and method of use thereof
WO2007066189A2 (en) *	2005-12-09	2007-06-14	Pfizer Products Inc.	Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea
CA2667720A1 (en) *	2006-11-09	2008-05-15	Abbott Gmbh & Co. Kg.	Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor

2008
- 2008-10-17 UA UAA201006029A patent/UA100865C2/en unknown
- 2008-10-17 JP JP2010529408A patent/JP2011500649A/en active Pending
- 2008-10-17 CA CA2699301A patent/CA2699301A1/en not_active Abandoned
- 2008-10-17 WO PCT/EP2008/064076 patent/WO2009050291A2/en not_active Ceased
- 2008-10-17 RU RU2010119929/15A patent/RU2010119929A/en not_active Application Discontinuation
- 2008-10-17 KR KR1020107010979A patent/KR20100087170A/en not_active Withdrawn
- 2008-10-17 CN CN200880112150A patent/CN101827584A/en active Pending
- 2008-10-17 BR BRPI0818340 patent/BRPI0818340A2/en not_active IP Right Cessation
- 2008-10-17 AU AU2008313622A patent/AU2008313622A1/en not_active Abandoned
- 2008-10-17 EP EP08839333A patent/EP2197425A2/en not_active Withdrawn
- 2008-10-17 MX MX2010004291A patent/MX2010004291A/en not_active Application Discontinuation
- 2008-10-17 PA PA20088800101A patent/PA8800101A1/en unknown
2010
- 2010-03-24 ZA ZA2010/02095A patent/ZA201002095B/en unknown
- 2010-04-16 GT GT201000102A patent/GT201000102A/en unknown
- 2010-04-16 DO DO2010000117A patent/DOP2010000117A/en unknown
- 2010-04-27 CO CO10049271A patent/CO6270206A2/en not_active Application Discontinuation
- 2010-05-17 EC EC2010010183A patent/ECSP10010183A/en unknown
- 2010-05-19 CR CR11442A patent/CR11442A/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
GT201000102A (en)	2012-03-12
WO2009050291A3 (en)	2010-04-08
CR11442A (en)	2010-09-06
UA100865C2 (en)	2013-02-11
KR20100087170A (en)	2010-08-03
ECSP10010183A (en)	2010-06-29
RU2010119929A (en)	2011-11-27
CO6270206A2 (en)	2011-04-20
AU2008313622A1 (en)	2009-04-23
DOP2010000117A (en)	2010-05-15
EP2197425A2 (en)	2010-06-23
PA8800101A1 (en)	2009-05-15
JP2011500649A (en)	2011-01-06
CA2699301A1 (en)	2009-04-23
WO2009050291A2 (en)	2009-04-23
CN101827584A (en)	2010-09-08
ZA201002095B (en)	2011-11-30
MX2010004291A (en)	2010-08-02

Publication	Publication Date	Title
BRPI0818339A2 (en)	2015-04-22	Solid dispersion product containing n-aryl urea compound
BRPI0816730A2 (en)	2019-09-24	product distribution system
EP2240022A4 (en)	2012-04-25	PHARMACEUTICAL COMPOSITIONS
BRPI0918652A2 (en)	2015-08-25	Pharmaceutical compositions and related release methods.
BRPI0821876A2 (en)	2015-06-23	Medication administration systems and methods
DK2692341T3 (en)	2015-06-22	Abuse-resistant drug formulation
BRPI0812861A2 (en)	2014-12-09	SAFETY LUER CONNECTION
BRPI0814639A2 (en)	2015-07-14	Charge monitor
DK2151438T3 (en)	2012-11-26	Medicinal product containing PPAR-Deltaagonist
BRPI0820381A2 (en)	2015-05-19	Pharmaceutical Formulations
HRP20181843T1 (en)	2019-01-11	ANIMAL MEDICINAL PRODUCT
BRPI0920521A2 (en)	2018-01-16	pharmaceutical combination
BRPI0721651A2 (en)	2014-04-01	PHARMACEUTICAL COMPOSITION
BRPI0912972A2 (en)	2015-08-04	Granulated Dairy Products
BRPI0817310A2 (en)	2015-03-17	Drug Monitoring Assay
EP2373681A4 (en)	2013-11-06	PHARMACEUTICAL COMPOSITIONS
BRPI0813753A2 (en)	2014-12-30	PREPREGNED PRODUCT
IL242028A0 (en)	2015-11-30	Micropump-operated drug dosing system
ATE531278T1 (en)	2011-11-15	CONFESSIONAL PRODUCT
EP2154966A4 (en)	2010-12-15	BENZIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS THEREOF
BRPI0807078A2 (en)	2014-04-08	COMPOUND AND PHARMACEUTICAL FORMULATION
BRPI0919331A2 (en)	2015-12-29	pyrazole pyridine derivatives, pharmaceutical compositions and associated methods
DK2120884T3 (en)	2011-02-07	Pharmaceutical composition
BRPI0818340A2 (en)	2015-04-22	N-Aryl Urea-based solid drug dispersion product
BRPI0921654A2 (en)	2016-02-10	pharmaceutical formulation

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application fees: dismissal - article 86 of industrial property law	Free format text: REFERENTE AS 6A E 7A ANUIDADES.
2016-04-05	B08K	Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.